Research Article
Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy
Figure 2
Univariate analysis of 267 T3-4aN0M0 gastric cancer patients. (a) The mean survival times of patients with tumor sizes smaller than 5 cm and larger than 5 cm were 63.25 and 47.95 months, respectively (). (b) The mean survival times of the T3 and T4a patients in the study were 59.61 and 45.89 months, respectively (). (c) Tumor location was also a prognostic factor for this group of patients (). (d) Adjuvant chemotherapy did not have a prognostic benefit for this group of gastric cancer patients ().
| (a) |
| (b) |
| (c) |
| (d) |